These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1031 related items for PubMed ID: 23681931

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
    Wang X, Zheng M, Raza F, Liu Y, Wei Y, Qiu M, Su J.
    Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
    [Abstract] [Full Text] [Related]

  • 24. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z, Zhang Y, Zhang K, Wu Z, Feng N.
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [Abstract] [Full Text] [Related]

  • 25. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X, Li X, Xiong L, Zhang X, Kleitz F, Qiao SZ.
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A, Kushwaha SS, Mishra A.
    Recent Pat Drug Deliv Formul; 2020 Jun; 14(2):126-144. PubMed ID: 32928094
    [Abstract] [Full Text] [Related]

  • 28. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Abnous K, Malaekeh-Nikouei B.
    Curr Drug Deliv; 2016 Jun; 13(7):1176-1182. PubMed ID: 26718488
    [Abstract] [Full Text] [Related]

  • 29. Functionalized mesoporous silica nanoparticles and biomedical applications.
    Hoang Thi TT, Cao VD, Nguyen TNQ, Hoang DT, Ngo VC, Nguyen DH.
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():631-656. PubMed ID: 30889738
    [Abstract] [Full Text] [Related]

  • 30. The Controlled Release of Drugs and Bioactive Compounds from Mesoporous Silica Nanoparticles.
    Chowdhury MA.
    Curr Drug Deliv; 2016 Jun; 13(6):839-56. PubMed ID: 26638978
    [Abstract] [Full Text] [Related]

  • 31. Biocompatibility of mesoporous silica nanoparticles.
    Asefa T, Tao Z.
    Chem Res Toxicol; 2012 Nov 19; 25(11):2265-84. PubMed ID: 22823891
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tailored Mesoporous Inorganic Biomaterials: Assembly, Functionalization, and Drug Delivery Engineering.
    Zou Y, Huang B, Cao L, Deng Y, Su J.
    Adv Mater; 2021 Jan 19; 33(2):e2005215. PubMed ID: 33251635
    [Abstract] [Full Text] [Related]

  • 34. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y, Han X, Jing X, Chen Y.
    Adv Healthc Mater; 2017 Sep 19; 6(18):. PubMed ID: 28795530
    [Abstract] [Full Text] [Related]

  • 35. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
    Feng Y, Liao Z, Li M, Zhang H, Li T, Qin X, Li S, Wu C, You F, Liao X, Cai L, Yang H, Liu Y.
    Adv Healthc Mater; 2023 Jun 19; 12(16):e2201884. PubMed ID: 36529877
    [Abstract] [Full Text] [Related]

  • 36. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D, Gao Y, Wang L, Liu G, Chen Y, Wang T, Tao W, Mei L, Huang L, Zeng X.
    J Colloid Interface Sci; 2016 Feb 01; 463():279-87. PubMed ID: 26550786
    [Abstract] [Full Text] [Related]

  • 37. Mesoporous silica nanoparticles in tissue engineering--a perspective.
    Rosenholm JM, Zhang J, Linden M, Sahlgren C.
    Nanomedicine (Lond); 2016 Feb 01; 11(4):391-402. PubMed ID: 26784861
    [Abstract] [Full Text] [Related]

  • 38. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
    Ahmadi F, Sodagar-Taleghani A, Ebrahimnejad P, Pouya Hadipour Moghaddam S, Ebrahimnejad F, Asare-Addo K, Nokhodchi A.
    Int J Pharm; 2022 Sep 25; 625():122099. PubMed ID: 35961417
    [Abstract] [Full Text] [Related]

  • 39. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
    Baeza A, Manzano M, Colilla M, Vallet-Regí M.
    Biomater Sci; 2016 May 26; 4(5):803-13. PubMed ID: 26902682
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.